Carrie Kitko, MD, Pediatric Hematology & Oncology, Nashville, TN, Monroe Carell Jr Children's Hospital at Vanderbilt

CarrieLKitkoMD

Pediatric Hematology & Oncology Nashville, TN

Associate Professor of Pediatrics Medical Director, Pediatric Stem Cell Transplant Program

Dr. Kitko is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kitko's full profile

Already have an account?

Education & Training

  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersFELLOWSHIP
  • Duke University Medical CenterCHIEF_RESIDENCY
  • Duke University Hospital
    Duke University HospitalRESIDENCY
  • The Ohio State University College of Medicine
    The Ohio State University College of MedicineMEDICAL_SCHOOL
  • Denison UniversityOTHER_TRAINING

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2020 - 2020
  • TN State Medical License
    TN State Medical License 2015 - 2022
  • MI State Medical License
    MI State Medical License 2003 - 2016
  • NC State Medical License
    NC State Medical License 2002 - 2004
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcome  
    Choi SW, Stiff P, Cooke K, Ferrara JLM, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE, Biol Blood Marrow Transplant, 1/1/2012
  • Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcome after unrelated donor transplantation for ch...  
    Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis..., Blood, 1/1/2012
  • Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies  
    Magenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P, Kitko C, Choi S, Yanik G, Frame D, Harris A, Erba H, Kujawski L, Elenitoba-Johnson K, Sanks J, Jones D, Pacz..., Blood, 1/1/2011
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
    Carrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Prepa...
    Carrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • National Institutes of Health (NIH) consensus criteria describe the clinical features of chronic graft-versus-host disease (cGVHD) in children and improve and accuracy...
    Cuvelier G, Nemecek E, Boyer M, Wahlstrom J, Kitko C, Jacobsohn D, Coulter D, Chewning A, McDonald S, Lewis V, Schechter T, Morris J, Halevy A, Schultz K, American Society of Blood and Marrow Transplant Meeting, Honolulu, HI, 1/1/2016
  • Join now to see all

Lectures

  • Efficacy of Methoxsalen Sterile Solution in Conjunction with the Therakos¬ Cellex¬ Photopheresis System in Pediatric Patients with Steroid-Refractory Acute GvHD: Inter... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Highlights from ASH 2014: Pediatric Hematology/Oncology 
    Dearborn, MI - 1/1/2015
  • Chronic GVHD Biomarker Discovery: A Pathway to Better Treatments 
    1/1/2014
  • Join now to see all

Press Mentions

  • New Cutting-Edge Treatment for Type of Pediatric Leukemia Offered at Monroe Carell Jr. Children’s Hospital at Vanderbilt
    New Cutting-Edge Treatment for Type of Pediatric Leukemia Offered at Monroe Carell Jr. Children’s Hospital at VanderbiltSeptember 18, 2017
  • Medical Staff, Theater Join Forces to Help Cancer Patient See ‘Star Wars’
    Medical Staff, Theater Join Forces to Help Cancer Patient See ‘Star Wars’January 21, 2016

Committees

  • Committee member, ASH Communications Committee

Professional Memberships

  • American Society for Blood and Marrow Transplantation
    Member

Hospital Affiliations